Faculty

Paul Beninger, MD, MBA (Program Director): Therapeutic Area Head, Global Pharmacovigilance and Epidemiology, Genzyme Sanofi; formerly Director, FDA CDRH Medical Device Division 

Paul Beninger, MD, MBA


Positions: Tufts Biopharma Program Director; Assistant Professor of Public Health and Community Medicine; Director, MD/MBA & MBS/MBA Programs

Education: MD, University of California, Davis, School of Medicine; MBA, Haub School of Business, St. Joseph’s University, Philadelphia

Research Interests: Development process of new drugs, biologics, vaccines, and medical devices; pharmacovigilance, including signal management and benefit-risk management; and regulatory science.   view full profile

Kenneth I. Kaitin, PhD: Research Professor and Director, Tufts CSDD, TUSM

Kenneth I. Kaitin, PhD


Positions:
Director, Tufts CSDD; Professor of Medicine and Public Health and Community Medicine, TUSM

Education: BS, Cornell University; MS and PhD, pharmacology, University of Rochester

Research Interests: Factors that contribute to the slow pace and high cost of pharmaceutical R&D and the impact of efforts to speed the drug development process.   view full profile

Joshua P. Cohen, PhD: Research Assistant Professor, Tufts CSDD, TUSM

Joshua P. Cohen, PhD


Positions:
Research Associate Professor, CSDD and TUSM

Education: MS and PhD, economics, University of Amsterdam

Research Interests: Patient access to newly approved oncology drugs in US and Europe; clinical, regulatory, and economic challenges facing pharmacogenomics; prescription-to-over-the-counter switches in US and Europe; trends in biosimilar market uptake.   view full profile

Joseph A. DiMasi, PhD: Research Assistant Professor and Director of Economic Analysis, Tufts CSDD, TUSM

Joseph A. DiMasi, PhD


Positions:
Director of Economic Analysis, Tufts CSDD; Research Associate Professor, TUSM

Education: PhD, economics, Boston College

Research Interests: R&D cost of new drug development, clinical success and phase attrition rates, development and regulatory approval times, the role that pharmacoeconomic evaluations have played in the R&D process, pricing and profitability in the pharmaceutical industry, innovation incentives for pharmaceutical R&D, and changes in the structure and performance of the pharmaceutical and biotechnology industries.   view full profile

Misha Eliasziw, PhD: Associate Professor, Public Health and Community Medicine, TUSM

Misha Eliasziw, PhD


Position:
Associate Professor of Public Health and Community Medicine, TUSM

Education: PhD, epidemiology and biostatistics, and MSc, statistics, University of Western Ontario

Research Interests: Applying mathematical and probabilistic methods to solve clinical and public health questions through numbers; advancing methodology in the areas of interrater agreement and intrarater reliability studies, which include inferences for the kappa statistic and intraclass correlation coefficient; currently collaborating in studies assessing the benefits of healthy eating and vitamin supplementation in school-age children.  view full profile

Kenneth Getz, MBA: Research Associate Professor and Director of CSDD Sponsored Research, Tufts CSDD, TUSM

Kenneth Getz, MBA


Positions:
Director of Sponsored Research Programs, CSDD; Research Associate Professor, TUSM

Education: MBA, Northwestern University; BA, Brandeis University

Research Interests: Pharmaceutical R&D management, protocol design complexity, R&D operating efficiency, R&D outsourcing and vendor management, global investigative site management, trends impacting the study conduct landscape, patient participation in clinical research.  view full profile

Christopher-Paul Milne, JD, DVM, MPH: Research Assistant Professor and Director of Research, Tufts CSDD, TUSM

Christopher-Paul Milne, JD, DVM, MPH


Positions:
Director of Research, Tufts CSDD; Research Assistant Professor, TUSM

Education: MPH, Johns Hopkins University; JD, University of New Hampshire Law School

Research Interests: Innovation efficiency and the globalization of R&D; tracking incentive programs for special patient populations and neglected diseases of the developing world; assessing the impact of emerging regulatory and reimbursement trends, and updating developments in new science and policy initiatives.  view full profile

Marcia M. Boumil, MS, JD, LLM: Associate Professor, Public Health and Community Medicine, TUSM

Marcia M. Boumil, JD, LLM


Position:
Associate Professor of Public Health and Community Medicine, TUSM

Education: MS, public health, Tufts University; MA, psychology, Boston College; JD, University of Connecticut School of Law; LLM, Columbia University School of Law

Research Interests: Conflicts of interest in academic medicine and legal issues in reproductive health and children’s mental health, particularly privacy issues.  view full profile

Olaf Dammann, MD


Position:
Professor of Public Health & Community Medicine, Pediatrics and Ophthalmology, TUSM

Education: MD, Hamburg University; SM, Harvard School of Public Health

Research Interests: The identification of perinatal risk factors for neonatal outcomes, computational systems population modeling, and the philosophy of epidemiology.

Deirdre McCarthy

Deirdre McCarthy


Positions:
Senior Director and Head, Lifecycle Safety Benefit-Risk Management Services, Quintlies; Adjunct Lecturer, Public Health and Community Medicine, TUSM

Education: MS, Pharmacavigilance, University of Hertfordshire

Chandrasekhar (Nat) Natarajan


Positions:
  Chief Scientific Officer at ViNa Pharma Consulting, LLC; Adjunct Lecturer, Public Health and Community Medicine, TUSM

Education: BPharm, and his MSc. in Pharmacology, University of Madras, India; MS, Pharmacotherapeutics, Long Island University.

Research Interests: The identification and mitigation of Absorption, Distribution, Metabolism, Excretion (ADME) and Pharmacokinetic (PK) issues for drug candidates within the discovery and development phase.

Daniel Bollag

Daniel Bollag, PhD


Positions:
Senior Vice President of Regulatory Affairs and Quality, ARIAD Pharmaceuticals Inc.; Adjunct Lecturer, Public Health and Community Medicine, TUSM

Education: PhD, biochemistry, Cornell University; BS, science, Pennsylvania State University; BA, French, Pennsylvania State University

Paul Jansen

Paul Jansen, PE


Positions:
aVP Medical Device Development, Sanofi US; Global Head Medical Device Development, Sanofi Germany; Head Device Development (PDS), Eli Lilly US; Global Head Field Service, Husky Injection Molding, Canada; Head Field Service, Philips Data Systems, Canada.

Education: BSC. Mechanical Engineering, University of Toronto, Graduate work Biomedical Engineering, University of Toronto.